cytidine has been researched along with Sclerosis, Systemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alarcón-Segovia, D; Estrada-Parra, S; Fishbein, E; García-Ortigoza, E | 1 |
| Lehmann-Brockhaus, E; Nietmann, H; Schick, P; Trepel, F | 1 |
| Begemann, H; Benedek, S; Eder, M; Fliedner, TM; Kaboth, W; Matzner, M; Schick, P; Theml, H; Trepel, F | 1 |
3 other study(ies) available for cytidine and Sclerosis, Systemic
| Article | Year |
|---|---|
Uracil-specific anti-R.N.A. antibodies in scleroderma.
Topics: Adenosine; Adenosine Monophosphate; Animals; Antibodies; Cattle; Cross Reactions; Cytidine; Cytosine Nucleotides; Epitopes; Guanine Nucleotides; Guanosine; Humans; Immunoelectrophoresis; Lupus Erythematosus, Systemic; Precipitins; RNA; Scleroderma, Systemic; Serum Albumin; Thymidine; Thymine Nucleotides; Uracil; Uracil Nucleotides; Uridine | 1975 |
Autotransufsion of 3H-cytidine-labelled blood lymphocytes in patients with Hodgkin's disease and non-Hodgkin patients. I. Limitations of the method.
Topics: Blood Transfusion, Autologous; Cytidine; Hodgkin Disease; Humans; Lymphocytes; Neoplasms; Scleroderma, Systemic; Time Factors | 1975 |
Autotransfusion of 3H-cytidine-labelled blood lymphocytes in patients with Hodgkin's disease and non-Hodgkin patients. II. Exchangeable lymphocyte pools.
Topics: Adult; Aged; Blood Transfusion, Autologous; Cytidine; Female; Hodgkin Disease; Humans; Lymphocytes; Male; Middle Aged; Neoplasms; Scleroderma, Systemic; Time Factors | 1975 |